Global Sleep Apnea Diagnostic Devices Market Insights Forecasts to 2030

• The Sleep Apnea Diagnostic Devices Market Size was valued at USD 5.1 Billion in 2021.
• The market Size is Growing at a CAGR of 6.9% from 2021 to 2030
• The Worldwide Sleep Apnea Diagnostic Devices Market is expected to reach USD 7.2 Billion by 2030
• Asia Pacific is expected to Grow the fastest during the forecast period

The Global Sleep Apnea Diagnostic Devices Market is expected to reach USD 7.2 Billion by 2030, at a CAGR of 6.9% during the forecast period 2021 to 2030.

Sleep Apnea is a sleeping disease that raises the risk of significant health issues like heart attacks, hypertension (high blood pressure), cardiomyopathy (enlargement of the heart's muscular tissue), and stroke. Even with a full night's sleep, untreated sleep apnea causes breathing to stop regularly while you sleep, resulting in loud snoring and daytime fatigue. Everyone can develop sleep apnea, but overweight older men are more likely to have it. About 25% of males and about 10% of women suffer from sleep apnea. All ages, including infants and children, are susceptible, but adults over 50 and those who are overweight are most vulnerable. Patients with obstructive sleep apnea frequently exhibit certain physical characteristics and clinical characteristics. They include excessive weight, a big neck, and anatomical anomalies that reduce the diameter of the upper airway, such as nasal blockage, a low-hanging soft palate, swollen tonsils, or a tiny jaw with an overbite. When the soft tissue in the back of the throat compresses during sleep, the airway is blocked, which results in sleep apnea. A polysomnogram (PSG), an overnight sleep study, and a home sleep test are used to diagnose this (HST).

COVID 19 Impact on Sleep Apnea Diagnostic Devices Market

On the sleep Apnea Devices Market, the COVID-19 epidemic is anticipated to have a substantial impact. According to a study published in January 2021 in the BMJ Open Respiratory Research, patients with obstructive sleep apnea (OSA) had a 2.93 times higher chance to be hospitalised when afflicted by COVID-19 than non-OSA persons. The study also made the recommendation that obstructive sleep apnea be acknowledged as one of the comorbidities risk factors for developing a severe form of the disease in the assessment of individuals who were suspected or confirmed to have COVID-19 infection. According to a report released in March 2022 by the Sleep Foundation Organization, COVID-19 changed and disrupted sleep patterns in a number of different ways. According to the article, research have shown that the prevalence of insomnia symptoms among adults, kids, and teenagers has substantially grown, and about 40% of people report having problems falling asleep. The market for sleep apnea products is anticipated to be impacted by this rise in sleep disorders even after the epidemic.

Key Market Drivers

Increasing cases of bone disorders is driving the market Growth

According to research from Sleep Science Resource, LLC, obstructive sleep apnea (OSA), which affects 18 million Americans, is considered to afflict 1 in 15 people in the nation. The prevalence of obesity, disrupted sleep patterns, high levels of stress, and cardiovascular problems has increased as a result of people's sedentary lifestyles. For instance, according to the article written by American Heart Association, Inc., several cross-sectional studies have revealed that severe sleep apnea is frequent in 40% of the obese population and that 70% of OSA patients are fat. According to data given by the European Respiratory Society, between 13.0% and 32.0% of Europe's elderly population experienced sleep apnea.

Due to increased rates of obesity and other lifestyle disorders, as well as rising sleep apnea diagnostic rates in both industrialised and developing countries, a significant patient pool must be treated or managed for the illness. This is encouraging market expansion, along with an increase in sleep clinics and sleep technologists globally. There is also a substantial number of undiagnosed patients, especially in developing countries. Through various efforts like "sleep awareness week," numerous NGOs and governmental organisations are working on boosting the awareness and diagnosis rates among these people. Additionally, it is anticipated that this will encourage market expansion in the next years. The market Growth for sleep apnea devices is therefore driven by this factor.

Increasing demand of the innovative products to propel the market growth

The trend of patients turning to technologically advanced devices has tremendously facilitated the development of novel treatments for sleep apnea. For instance, the use of oral devices like the mandibular advancement device (MAD) for OSA treatment has increased as a result of patient dissatisfaction with CPAP machines. According to statistics released by NCBI based on numerous research conducted in different nations, it is also projected that the compliance rate for CPAP machines among users has declined by up to 50.0%. Oral appliances, which have proven to be effective and offer comfort to patients throughout the treatment of the disorder, have been introduced to the market as alternatives as a result.

Restraining Factors

The high cost of devices to affect the market growth

The market's expansion is likely to be hampered by the high cost of diagnosing sleep apnea. For instance, a polysomnography machine used in an overnight sleep clinic, which normally costs between US $1,000 and US $3,000, is mostly used to diagnose OSA. These tests occasionally come with additional expenses for data interpretation. It makes patients more financially responsible, which is likely to be a barrier to the market's expansion.

Market Segmentation

Product Insights

The therapeutic devices segment is going to dominate the market over the forecast period.

On the basis of product, the market is segmented into Diagnostic Devices, Therapeutic Devices, Sleep Apnea Masks. Among these, the therapeutic devices segment is anticipated to dominate the market over the forecast period. Some of the primary growth factors include the increasing prevalence of OSA, improving awareness levels of OSA, ongoing technology advancements in devices, increased government support and initiatives, and rising disposable income.

The Sleep apnea masks market, on the other hand, is predicted to expand at the fastest rate. Some of the main drivers of the segment's growth include the widespread use of sleep apnea masks, rising rates of comorbidities linked to OSA, and increased adoption rates of CPAP machines for disease treatment.

End User Insights

Home care setting segment to witness the fastest market growth over the forecast period.

On the basis of end user, the market is segmented into Home Care Settings and Sleep Laboratories & Hospitals. Among these, the home care setting segment is anticipated to witness the fastest market growth over the forecast period. Companies in the industry are focusing on creating cutting-edge, portable devices that patients undergoing treatment for the condition can use at home. This and the growing trend towards treating OSA at home, notably in countries like the United States, the United Kingdom, Germany, and Japan, among others, are driving up the need for these devices in homecare and other settings.

Regional Insights

North America dominates the market with the largest market share over the forecast period.

In terms of share, the North America region dominated the market in 2022. Some of the main drivers of the expansion are shifting lifestyles, rising disposable income, the presence of well-known players, an increase in the number of obese people, an increase in the prevalence of respiratory disorders, an increase in OSA awareness, and supportive government measures. Philips Respironics, Somnetics International Inc., and ResMed are a few of the major players in North America. These businesses have a significant market presence and reliable supply and distribution networks across North America.

Due to the increased prevalence of lifestyle diseases like cancer, diabetes, hypertension, and chronic respiratory ailments, as well as the growing senior population, the Asia Pacific sleep apnea device market is anticipated to expand at the quickest CAGR between 2022 and 2030. Over 227 million people in the Asia Pacific region have been diagnosed with type 2 diabetes, according to the OECD iLibrary entry on Asia/Pacific 2020. Moreover, the region's fastest growing market for sleep apnea devices was India, while China retained the greatest market share.

The second-largest market share is held by the sleep apnea device market in Europe. This can be attributed to rising diagnostic testing demand, increased awareness of sleep apnea, favourable reimbursement environments, and expanding device penetration in this field. For instance, on September 15, 2022, ProSomnus, a pioneer in precision medical devices for the management of OSA, announced that the ProSomnus EVOTM Sleep and Snore Device is now officially covered by the German public health insurance system. Moreover, the UK sleep apnea device market had the biggest market share, while the Germany sleep apnea device market had the quickest rate of growth in the area.

Key Market Developments

• In February 2021, In order to create cutting-edge neurostimulation treatments for OSA, Nyxoah SA and Vanderbilt University formed a strategic relationship.

• In August 2021, ResMed, a pioneer in digital health and the treatment of sleep apnea, presented AirSense 11, their next-generation Positive Airway Pressure (PAP) device.

List of Key Market Players

• CADWELL INDUSTRIES INC
• DEVILBISS HEALTHCARE
• KONINKLIJKE PHILIPS N.V. (PHILIPS)
• MEDTRONIC PLC
• MINDRAY MEDICAL INTERNATIONAL LIMITED
• NATUS MEDICAL INCORPORATED
• NIHON KOHDEN CORPORATION
• RESMED INC
• SMITHS GROUP PLC. (SMITHS MEDICAL)
• SOMNOMEDICS GmbH

Market Segment

This study forecasts revenue at global, regional, and country levels from 2019 to 2030. Spherical Insights has segmented the global Sleep Apnea Diagnostic Devices Market based on the below-mentioned segments:

Sleep Apnea Diagnostic Devices Market, Product Analysis

• Diagnostic Devices
• Therapeutic Devices
• Sleep Apnea Masks

Sleep Apnea Diagnostic Devices Market, End User Analysis

• Home Care Settings
• Sleep Laboratories & Hospitals

Sleep Apnea Diagnostic Devices Market, Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of Middle East & Africa